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Abstract: Brucellosis is a widespread zoonotic disease considered as an emerging and re-emerging disease
with a resulting threat of public health and animal health. Official reports document an animal incidence
in Kazakhstan of about 0.6% per year, and the country still registers high number of human cases annually
. The main objective of this paper was to evaluate the distribution and economic impact of brucellosis
in Kazakhstan. We analysed human disease incidence data obtained from the Government Sanitary
Epidemiological Service with the aim to estimate the burden of disease in terms of disability-adjusted
life years (DALYs). We also estimated the economic impact in terms of monetary losses. Additionally,
we mapped the geographical distribution of the disease throughout Kazakhstan. In total, 1,334 human
cases of brucellosis were registered in 2015 in Kazakhstan that resulted in 713 DALYs. Around US Dollar
21 million was spent on compensation for animals that had to be slaughtered due to brucellosis, and an
additional US Dollar 24 million was spent on testing animals. Animal brucellosis and human brucellosis
occur throughout the whole country, some trends of which are reviewed in this paper. We estimated the
burden of the disease and explored possible explanation for high human incidence rates. This paper is
the first to estimate the human burden of disease and the economic costs in Kazakhstan. Both of these
are substantial.
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 The economic impact of brucellosis in Kazakhstan is substantial resulting in $45 million per 
annum associated with animal testing and compensation
 Over 1300 cases of human brucellosis were reported in 2015 in Kazakhstan resulting in an 
incidence of 7.6 cases per 100,000.
 Human brucellosis results has a burden of over 700 Disability Adjusted Life Years per 
annum in Kazakhstan 
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Brucellosis is a widespread zoonotic disease considered as an emerging and re-emerging 
disease with a resulting threat public health and animal health. Official reports on animal prevalence 
in Kazakhstan are about 0.6% per year and country still registers high number of human cases per 
year. The main objective of this paper was to evaluate the distribution and economic impact of 
brucellosis in Kazakhstan.
We analyzed human disease incidence data obtained from the Government Sanitary & 
Epidemiological Service with the aim to estimate the burden of disease in terms of Disability-
Adjusted Life Years (DALY). We also estimated the economic impact in terms of monetary losses.  
We also mapped the geographical distribution of the disease throughout Kazakhstan. In total 1334 
human cases of brucellosis were registered in 2015 in Kazakhstan that resulted in 713 DALYs. 
Around $21 million was spent on compensation for animals that had to be slaughtered due to 
brucellosis and an additional $24 million was spent on testing animals.
 Animal and human brucellosis occurs throughout the whole country, some trends of which 
are reviewed in this paper. We estimated the burden of the disease, and explored possible 
explanation for high human incidence rates. This paper is the first to estimate the human burden of 
disease and the economic costs in Kazakhstan. Both of these are substantial.  
Keywords: Brucellosis, Brucella, Epidemiology, Economic impact, Burden of diseases, 
Kazakhstan. 
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Kazakhstan has one of the highest incidences of human brucellosis worldwide with a reported 
annual incidence of 11.6 annual cases 100,000 of population (FAO, 2015).  During 2001 – 2006 an 
obligatory vaccination was implemented with varying levels of coverage. This was then replaced by 
a test and slaughter program in 2007 and continues until the present time. The present programme 
relies on a biannual screening. Sero-positive animals are slaughtered, and the owners are 
compensated at market value. Thirty percent of compensation comes from Government, and the rest 
(70%) comes from slaughterhouses. Since 2009, animal identification (tags or microchips) of the 
herds and registration of all cattle to facilitate the tracking of sero-positive animals were introduced 
(Grushina et al, 2010).
Previously no economic and disease burden were estimated for Kazakhstan. We used data on 
human incidence from data officially reported to the government epidemiological and sanitary 
services to estimate the burden of human brucellosis in Kazakhstan. We used data on animal 
prevalence obtained through the results of routine screening for brucellosis to map the prevalence of 
animal brucellosis. We also estimated the economic effects of animal vaccination program and the 
costs associated with compensation for slaughtered animals. 
2. Materials and Methods
2.1 Brucellosis diagnosis
Samples from both cattle and small ruminants are routinely screened by republican veterinary 
laboratories (RVL). There are 196 branches of RVL throughout the country on different 
administrative levels. Animals are screened twice each year: the first in spring prior to grazing in 
summer pastures; and the second test in autumn before their return to stalls. Bulls are tested 4 times 
a year. Breeding cows or ewes are tested before parturition. Young stock (cattle) are tested at the 
age of 4-6 months with I-ELISA. Sheep and goats at the age of 3-4 months tested with the Rose 
Bengal Test (RBT) and complement fixation test (CFT). 
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Each branch of the RVL operates under the same standardized operating procedures (SOPs). 
Blood serums are routinely collected from all animals by field veterinarians and delivered to the 
laboratory. Samples are first analyzed using the RBT and any positive tests are confirmed by CFT 
in dilution 1/5 - 1/20 and by the serum agglutination test (SAT). 
If routine screening results in positive cases in a previously disease free herd, the same blood 
samples should be retested within 15 to 20 calendar days by SAT and CFT. If results are positive 
again animals are then sent to slaughter house within 5 calendar days [4].
Laboratories perform RBT according to OIE recommendations. Standard RBT using 30 μl 
antigen/30 μl serum are used in cattle (OIE 2017). In small ruminants and deer, the laboratory uses 
modified RBT in order to increase the sensitivity of the test using 15 μl antigen and 30 μl serum. 
Both negative and positive controls are included. 
2.2 Animal data
Data was extracted from the results of screening tests run by RVL. RVL district branches do not 
routinely isolate Brucella from bacterial cultures to confirm species identification. Some samples 
were confirmed through cultures at the central Kazakh Scientific Veterinary Research Institute 
(KSRVI) in 2015. 
2.3 Human data
Precise anonymised data on brucellosis obtained from the Government Sanitary & Epidemiological 
Service. Cases reported are only those with a confirmed positive blood culture. The data also shows 
number of affected for children and adults
2.4 Costs 
Costs were estimated as the funds spent on screening tests performed twice a year by local branches 
of the RVL. Administrative divisions of Kazakhstan to village, district, and region facilitate 
screening throughout country. Each village has its own veterinarians and technicians that perform 
screening and then send the serum samples to the local RVL branch. 
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All the animals tested positive must be slaughtered and compensated by the Government. Current 
compensation policy states that animals found to be positive in serological tests  should be sent to a 
slaughterhouse. Additional laboratory tests should be taken within of 15 days of a positive 
serological test result. The slaughter of those animals can only be performed in a state approved 
slaughterhouse in the presence of the animal owner, state chief veterinarian of that administrative 
unit and chief state veterinary inspector. If there are pathological changes in organs and tissues this 
meat is sent to be cured for sausages or processed for canned meat and owners are compensated 
30% from the local administration from the budget which is allocated yearly (brucellosis is in the 
list of diseases for compensation) and 70% compensation is paid by the slaughterhouse . 
Blood samples are taken and RBT and SAT tests are undertaken.  Animals that are positive in 
either test are retested with SAT and the sample is additionally tested by the CFT test.  If the animal 
tests positive on either of these two tests it is considered positive. All animals are tested twice 
yearly with breeding bulls being tested four times a year.   Using price list given published by the 
Republican Veterinary Laboratories (RVL, 2017)   we estimated costs spent on annual screenings. 
We also estimated compensation costs. 
2.5 Disability adjusted life years
DALY for brucellosis were estimated using established techniques (Devleesschauwer et al, 
2014a,b). We calculated DALYs deterministically without age weighting. When calculating years 
of life lost (YLL), we used projected life expectancy by WHO for 2050, which is 92 years (WHO, 
2013).  As we have only data on number of human cases without any indication of the severity of 
disease, we estimated Years Lost due to Disability (YLD) using a Disability Weight (DW) 
suggested as 0.150 for chronic brucellosis (Dean et al 2012). The DW is a weighting  that reflects 
the severity of the disease on a scale from 0 which is used for indication of perfect health to 1 that 
is equivalent to death. A study of human brucellosis in Macedonia of 550 patients described the 
median duration of illness prior to diagnosis to be 30 days, whilst duration of treatment was 45 
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days, thus making the total duration of 75 days (Bosilovski et al. 2010). This was similar to the 
duration of disease reported in Dean et al (2016) although the latter only reported data from two 
studies with a total of 280 cases. Therefore, a duration of 75 days was used for the YLDs. In 
Germany from 6269 brucellosis cases reported between 1962 and 2005, there were 58 deaths, 
resulting in a case fatality rate of 0.9%. (Al Dahouk et al 2007). This case fatality rate was used to 
estimate the number of fatal cases in Kazakhstan to calculate the YLLs. The official data was only 
recorded as cases in children up to 18 years (19.4%) and adults (80.6%). This indicated a greater 
proportion of cases in adults compared to the census data as 31% of the population is under 18 (data 
from United States Census Data – International Programmes: https://www.census.gov/programs-
surveys/international-programs/data.html). By comparing the proportion of cases in children and 
adults to census data we estimate that the mean age of reported cases is 36 years (i.e. older than the 
mean age of the Kazakh population of 32 years). The estimated mean age of 36 was used as the age 
of death to estimate YLLs in fatal cases, giving a mean residual life expectancy of 56 years
2.6 Analysis
In order to test the hypothesis that there is a correlation between animal incidence and human 
incidence, we analyzed number of cases in humans using generalized linear models (from MASS 
package in R) (Venables, 2002) with cases in small ruminants and cattle as independent variables.  
We used a negative binomial link function so that over-dispersion of human cases could be 
adequately captured, with an offset variable for population sizes. Thus any significant association 
between the numbers of animal cases reported each year and human cases each year at the Oblast 
level would be illustrated. Likewise any relationship between cattle and sheep incidence was also 
analyzed. Data on animal prevalence allowed us to map annual prevalence using maptool package 
in R (Lewin-Koh et al (2017).  The GIS data with Kazakhstan’s outlines and administrative 
subdivisions was downloaded from an open source as zip file (DIVA-GIS 2017). 
All data is provided in a supplementary file (S1 data set)
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The annual prevalence rates registered in cattle during 2006, 2007 were around 0.30% (3 per 1000) 
on a national level.  This increased to 0.79% in 2008, and peaked at 1.85% in 2009. Between 2013-
2015 it has been fluctuating at around 0.6% (figure 1). According to the results of the screening 
tests in 2015, the percentage of positive reacting cases varied from 0.06% to over 2.5% for cattle 
depending on the subregion. The regional variability of cases in cattle reported at district level is 
illustrated in figure 2. In small ruminants the annual percentage incidence was generally between 
0.15 and 0.3%, with peak numbers reported in 2013 (0.5%) and 2008 (0.65%) (Figure 3).  The 
variation in percentage of positive cases was from 0.01% to 2.5% at the district level (Figure 4) . 
There was evidence of a positive association of cattle incidence with sheep incidence at the rayon 
level (p<0.001). In 2015-2016 KazSRVI identified 35 isolates in different regions (Table 3). They 
were identified from biological samples collected in different regions of West Kazakhstan, and 
Almaty in 2015 and Kostanay, East Kazakhstan and Almaty in 2016. Mostly B.abortus strains were 
isolated in cattle and B.melitensis in sheep. However there are some cases in Kaztalovskiy district 
of the West Kazakhstan region where B.melitensis was isolated in cattle.
3.2 Human incidence and disease burden.
Human data analysis showed decreasing in incidence throughout last 10 years, reaching its peak in 
2006 – 17,4 per 100.000 population affecting 2670 people, and its lowest point in 2015 – 7,7 per 
100.000 (Figure 5).  In 2015, 1334 human cases of brucellosis were registered in Kazakhstan from a 
population of about 17 million inhabitants (in 14 regions and 2 large cities). Of these 1131 were 
registered in rural inhabitants. Regional incidences varied from less than 1 case per 100,000 in 
Mangghystau region to over 20 cases per 100,000 in Zhambyl region (Figure 6).  Of the 1334 cases, 
926 were confirmed by hemoculture. This resulted in approximately 672 YLLs and 41 YLDs with a 
total of 713 DALYs or a mean of approximately 0.5 DALYs per case. Only 1 percent of cases are 
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associated with professional activity such as veterinarian, or laboratory worker. The highest 
incidence is registered in Almaty, East Kazakhstan, Zhambyl and Qyzylorda regions. The GLM did 
not show any geographical association between incidences in human with incidences in livestock 
species.
3.3  Costs 
 Average compensation throughout the country is approximately 3.2 USD per kilo for recoverable 
meat. Around 34,000 sheep with average weight of 15kg of recoverable meat were slaughtered in 
2015, resulting 1 632 000 USD. In addition, 41,010 heads of cattle with average weight of 150kg of 
recoverable resulting 19 684 800USD.  This resulted in a total of 21 316 800 USD for 
compensation. We used 3.2 USD per kilo as an average price for both types of meat retrieved from 
small and large ruminants. The difference between the price is only around 100 KZT that equals 
0.27 USD  and there is greater regional variation in the price than between species.
Given that each animal is tested at least twice a year with two tests in parallel (RBT and 
CFT) and then confirmatory test we used 8 tests as a number of tests performed on a positive animal 
and 4 tests on a negative animal.  In 2015, around 6.8 million of heads of cattle were tested and 17 
million of heads of sheep and goats. RBT and CFT together cost 330 KZT which is roughly 1 USD, 
and SAT and CFT together used for diagnosis confirmation cost 334 KZT which is also around 1 
USD, resulting in total costs of testing of US$ 24 million (Table 1).  The total costs of screening 
and animal compensation therefore is $45,239,000
As an alternative scenario we estimated the costs of a vaccination programme for mass 
vaccination of young animals (both large and small ruminants) using OIE approved vaccines as just 
over $2 million (Table 2). Vaccination of young animals was suggested by many OIE brucellosis 
experts and EU working documents on elimination of brucellosis, given that prevalence of 
brucellosis in animals is low (less than 5%) and sufficient veterinary services are in place (Hunter, 
2001). Provided that state veterinarians involved in brucellosis control program are on a fixed 
salary, implementation of the vaccination should not create added labor costs. Fixed labor costs, 
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which have not been estimated, would be similar for this scenario compared to the present control 
programme.
4. Discussion
Brucellosis surveillance facilitates the control of infection. Despite the improvement of 
epidemiological surveillance brucellosis continues to remain a substantial problem certain rural 
districts and regions of the country. 
In this study we used available data given per district for each region of Kazakhstan.  The 
complexities of delivering planned screenings and control measures is increased by  many small and 
large farms with mixed type of animals. Most villages in Kazakhstan have several households with 
animals that are kept on common pastures and animal movement are usually not monitored. Only 
when data on animal movement and prevalence in those small villages becomes available will it 
become possible to undertake a more detailed analysis. 
Analysis of the available data demonstrated that the disease prevalence varied between 
different districts of Kazakhstan. Over much of the country, there was a moderate prevalence of 
around 0.7-1.3% in cattle.  Low prevalence regions include Mangghystau, Qyzylorda, Zhambyl, 
North-Kazakhstan and Almaty  with prevalence at around 0 - 0.2%.  
In 2015, West Kazakhstan (1.48%) and Pavlodar (1.66%) registered the highest prevalence, 
with a few districts in Akmola region reporting prevalences as high as 4.1% in both small and large 
ruminants. This was due to a major outbreak of brucellosis.  Data on isolated Brucella species in 
ruminants clearly showed sheep-cattle relationship. Out of 16 isolates found in cattle 2 were of a 
B.melitensis and the rest of B.abortus. However data on number of notified abortions and 
subsequent results of bacteriological analysis is not available.
The GLM did not show any geographical association between incidences in human with 
incidence in livestock. Human incidence data was only available at regional level. More detailed 
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data on human incidence in future might help to further explore  possible correlations with animal 
incidence and between between strains infecting humans and animals.  
The 1334 human cases of brucellosis resulted in an estimated 713 DALYs which is higher 
than the burden of disease compared to that reported for rabies in Kazakhstan (Sultanov et al, 2016). 
The burden of disease is similar to that in neighboring Kyrgyzstan (Cournotte et al. 2016), although 
the population of Kazakhstan is somewhat larger.   The human disease incidence appears to be 
decreasing despite a relatively stable incidence in animals. The reasons for this are not yet clear but 
it is possible to speculate, for example, that milk is more frequently consumed following 
pasteurization than previously. 
The test and slaughter program implemented in Kazakhstan, on its own, might not be 
sufficient to control and eliminate the disease. Because of the varying prevalence between districts, 
it might be helpful to apply different regional strategies. In regions with high prevalence mandatory 
vaccination should be considered. However, authorities should decide if mass vaccination of all 
animals or vaccination of only young and replacement animals should be undertaken. Regions with 
no brucellosis or a low incidence should ensure that the disease is not introduced Thus strong 
movement control of new introduced and trade animals is needed. If mandatory vaccination is 
applied it should be undertaken using OIE approved vaccines. In our paper we estimated the budget 
needed to implement vaccination of young animals which is considerably less than the present test 
and cull programme.   In Mongolia, vaccination of livestock appears to be highly cost effective in 
terms of reducing the human burden of disease (Roth et al. 2003)   
Current control strategies including annual screening is based on serological testing of all 
animals at least twice a year using both RBT and CFT. Positively reacting animals have to be 
retested in 15-30 days by CFT and SAT. These numerous tests performed on one animal result in 
substantial costs to the government. We estimated it to be around 24 million USD. OIE terrestrial 
code suggests using sensitive test as a screening tool and more specific test for confirmation, thus 
using only RBT as a screening and CFT as confirmatory test. Therefore, running only 2 tests on 
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positive animal.  Using such a  screening strategy might decrease the cost by 50%. The cost savings 
could be used to implement improved strategies against brucellosis or against other zoonotic 
diseases.
There were a number of study limitations. The burden of human disease was estimated from 
the reported incidence of disease. Data on human fatalities caused by brucellosis was not available 
and was estimated from other data. Likewise details of the age related incidence, other than broad 
categories of adult and child were not available. The duration was assumed to be relatively short as 
cases received treatment. However, the DALY is driven by the case fatality rate and the duration of 
disease. Thus for untreated cases there could be chronic sequelae that would dramatically increase 
the duration of disease and hence the YLDs. If the case fatality rate is substantially different from 
that assumed, this could also have a dramatic effect of the YLLs. It is also possible that there are 
further unreported cases. Likewise, the incidence in livestock may be under reported due to 
limitations of the diagnostic tests or failure to test some animals. There is also a lack of data on the 
species of Brucella effecting both humans and animals which would also have an effect on the 
severity of disease. Finally, the economic effects in animals are only presented as costs, as they 
result from efforts to control the disease. The burden of animal disease such as the financial burden 
or through other metrics (Torgerson et al. 2018) is not possible to estimate without detailed 
production losses due to Brucellosis and an estimate of duration of infection before affected animals 
are culled.
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S1 Dataset. Data sets. This ZIP file contains all the data used in the manuscript.
Legend for figures.
Figure 1 Annual incidence (per cent) of brucellosis in cattle from 2006 to 2015.
Figure 2. Incidence of brucellosis (% or cases per 100)  in cattle in 2015.
Figure 3. Annual incidence of brucellosis (% of cases per 100)  in sheep and goats during 2006-
2015.
Figure 4.  Incidence of brucellosis (% or cases per 100)  in small ruminants in 2015.
Figure 5. Annual incidence (cases per 100,000) of brucellosis in human from 2006 to 2015.
Figure 6. Incidence of human brucellosis (cases per 100,000) in Kazakhstan in 2015.
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Figure 1. Annual incidence (per cent) of brucellosis in cattle from 2006 to 2015. 
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Figure 2. Incidence of brucellosis (% or cases per 100)  in cattle in 2015. 
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Figure 3. Annual incidence of brucellosis (% of cases per 100)  in small ruminants during 2006-2015. 
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Figure 4.  Incidence of brucellosis (% or cases per 100)  in small ruminants in 2015. 
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Figure 5. Annual incidence (cases per 100,000) of brucellosis in human from 2006 to 2015. 
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Figure 6. Incidence of human brucellosis (cases per 100,000) in Kazakhstan in 2015. 
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Large ruminants 6,183,900 6 785 465 40 973 6 785 465 40 973
Small ruminants 18, 015,500 17 061 778 34 610 17 061 778 34 610
Total 23 922 826 USD
* Some animals tested on multiple occasions, as described in text.
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2007  2008  
 
Planned 




Tested Positive inc. 
 
Planned Tested Positive inc. 
. 
 
1 Akmola 257 200 257 200 406 0,16 654400 654400 1431 0,22 181500 181500 1718 0,95 
2 Aktiobinsk 492 800 492 800 3 057 0,62 507000 507000 3037 0,60 368200 368200 7649 2,08 
3 Taldykorgan region  459833 459833 259 0,06 461350 461350 308 0,07 318450 318450 217 0,07 
4 Almaty region 530 589 530 589 821 0,15 538780 538780 564 0,10 365845 365845 628 0,17 
5 Atirau 135 125 135 125 271 0,20 173000 173000 483 0,28 141367 141367 1073 0,76 
6 East Kazakhstan Oblast 599873 599873 1 376 0,23 573000 573000 1141 0,20 381300 381300 3609 0,95 
7 Zhambul 382 993 382 993 691 0,18 376450 376450 720 0,19 335028 335028 2865 0,86 
8 West Kazakhstan Oblast 622 377 622 377 4 836 0,78 566000 566000 5732 1,01 387100 387100 5855 1,51 
9 Karaganda 395 582 395 582 2 903 0,73 374160 374160 3452 0,92 313160 313160 3380 1,08 
10 Zhezkazgan region  61 030 61 030 125 0,20 88430 88430 101 0,11 78730 78730 101 0,13 
11 Kostanai 572 408 572 408 1 195 0,21 740000 740000 1376 0,19 451500 451500 5171 1,15 
12 Kyzylorda 251 114 251 114 355 0,14 250000 250000 259 0,10 249740 249740 473 0,19 
13 Mangistau 12 638 12 638 0 0,00 14800 14800 0 0,00 10900 10900 0 0,00 
14 Pavlodar 473 615 473 615 2 763 0,58 454505 454505 2492 0,55 310660 310660 4280 1,38 
15 Semipalatinsk region  410 550 410 550 959 0,23 427000 427000 672 0,16 288400 288400 1973 0,68 
16 North kazakhstan Oblast 561 000 561 000 348 0,06 682000 682000 315 0,05 312800 312800 375 0,12 
17 South Kazakhstan Oblast 782 126 782 126 460 0,06 743520 743520 346 0,05 538719 538719 488 0,09 
  
Total: 




22 429 0,29 5 033 
399 
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2009  2010  2011  
Planned 
Tested Positive inc. 
 
Planned Tested Positive inc. 
. 
 
Planned Tested Positive inc. 
 
1 Akmola 483 800 483 800 8 828 1,82 498 560 498 560 6 667 1,34 654010 245674 3108 1,27 
2 Aktiobinsk 517000 517000 21 549 4,17 553 550 553 550 16 321 2,95 766080 260139 6697 2,57 
3 Taldykorgan region  425120 425120 204 0,05 427120 427120 499 0,12 650640 240307 368 0,15 
4 Almaty region 536380 536380 693 0,13 560 740 560 740 681 0,12 736160 244849 34 0,01 
5 Atirau 184200 184200 4505 2,45 225 900 225 900 3 645 1,61 292940 93928 1038 1,11 
6 East Kazakhstan Oblast 506182 506182 9339 1,84 576100 576100 4 435 0,77 755482 276571 2113 0,76 
7 Zhambul 347000 347000 2255 0,65 438 750 438 750 2 978 0,68 506300 190459 2071 1,09 
8 West Kazakhstan Oblast 506 700 506 700 32 943 6,50 541 740 541 740 22 130 4,08 700430 199686 10395 5,21 
9 Karaganda 414010 414010 9186 2,22 414 800 414 800 4 697 1,13 651200 185912 3710 2,00 
10 Zhezkazgan region  100390 100390 867 0,86 100 400 100 400 574 0,57 113400 30066 345 1,15 
11 Kostanai 609900 609900 11975 1,96 520 900 520 900 7 385 1,42 991010 337888 3532 1,05 
12 Kyzylorda 247300 247300 686 0,28 308 610 308 610 777 0,25 399940 153786 650 0,42 
13 Mangistau 11000 11000 49 0,45 12 660 12 660 8 0,06 18600 5345 9 0,17 
14 Pavlodar 427200 427200 12007 2,81 448 610 448 610 7 635 1,70 676680 253900 3255 1,28 
15 Semipalatinsk region  426018 426018 11338 2,66 378 000 378 000 4 485 1,19 624313 237355 2318 0,98 




835800 835800 777 0,09 1 023 268 1 023 268 1 330 0,13 1195150 317464 602 0,19 
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Table  3   Incidence in cattle in 20122016 
 
District Designation 

























530517 2504 0,47 199 354 537 0,3 258275 943 0,4 250481 917 0,37 
277396  2180 0,78 
Aktiobinsk 653684 4400 0,67 492 768 4 553 0,97 342177 3851 1,1 431850 3358 0,78 291806 2435 0,8 
 Atirau  226030 964 0,43 184 282 1 428 0,8 150 230 852 0,5 169302 131 0,46 95982 543 0,56 
Almaty  1370656 981 0,08 726 601 997 0,1 1033693 795 
0,0
7 
980461 1213 0,12 
1171078 977 0,08 
East Kazakhstan 
Oblast 
1279799 4805 0,37 665470 3 837 0,6 416800 2304 1,4 851577 6458 0,74 
660911 4065 0,62 
Zhambul 500000 970 0,19 306 470 724 0,2 329007 0 0 383549 627 0,16 222583 299 0,1 
West Kazakhstan 
Oblast 
493595 6319 1,28 323 217 4 773 1,5 369 035 6 601 1,7 552283 8164 1,48 386958 5608 1,46 
Karaganda 826000 4139 0,38 343 331 3 895 1,0 416094 5026 0,9 503831 4574 0,62 442871 2595 0,6 
Kyzylorda 344 529 195 0,06 259 061 135 0,13 231181 68 0 273238 56 0,02 214361 24 0,01 
Kostanai  606723 4099 0,68 329 832 2 321 0,7 414 654 4 682 1,1 535379 5247 0,98 332269 3545 1,1 
Mangistau  16115 5 0,03 13 736 0 0 15560 0 0 17554 0 0 14267 0 0 
Pavlodar 495600 3295 0,66 327 701 3 050 0,9 350101 4764 1,3 402994 6690 1,66 305550 3057 1,00 
North kazakhstan 
Oblast 
467589 1125 0,24 260 147 585 0,2 383 277 682 0,2 386947 401 0,1 
244512 863 0,35 
South Kazakhstan 
Oblast 
1282656 446 0,03 947 099 332 0 854970 497 0 895335 558 0,06 
472068 473 0,1 
Astana city 1635 0 0 89 023 1 646 1,8 99929 1710 1,7 150684 1932 1,28 333 6 1,8 
Total 9095128 34247 0,3 5468092 28813 0,6 5546171 32775 0,6 6785465 40973 0,6 4918798 26670 0,6 
Page 28 of 47
























































2006  2007  
 
2008   
Planned 
Tested Positive inc. 
 
Planned Tested Positive inc. 
 
Planned Tested Positive inc. 
 
1 Akmola 97 631 97 631 5 0,01 245000 245000 34 0,01 109000 109000 88 0,08 
2 
Aktiobinsk 594 836 594 836 1131 0,19 451000 451000 832 0,18 590000 590000 1364 0,23 
3 
Taldykorgan region  1339843 1339843 1604 0,12 1478450 1478450 1343 0,09 1062170 1062170 2461 0,23 
4 
Almaty region 1 248 329 1 248 329 1958 0,16 1495010 1495010 1948 0,13 1071825 1071825 1901 0,18 
5 
Atirau 459 655 459 655 139 0,03 365000 365000 117 0,03 277200 277200 261 0,09 
6 East Kazakhstan Oblast 726 065 726 065 2033 0,28 564000 564000 761 0,13 585352 585352 3119 0,53 
7 
Zhambul 1 943 942 1 943 942 10660 0,55 2271835 2271835 11256 0,50 1506257 1506257 51148 3,40 
8 West Kazakhstan Oblast 422 144 422 144 755 0,18 322000 322000 367 0,11 418000 418000 407 0,10 
9 
Karaganda 385 857 385 857 1674 0,43 320840 320840 669 0,21 371290 371290 692 0,19 
10 Zhezkazgan region  146 300 146 300 0 0,00 119950 119950 0 0,00 210150 210150 18 0,01 
11 Kostanai 163 703 163 703 152 0,09 175000 175000 59 0,03 161700 161700 77 0,05 
12 Kyzylorda 567 471 567 471 690 0,12 942000 942000 795 0,08 571960 571960 915 0,16 
13 
Mangistau 301 370 301 370 0 0,00 316000 316000 0 0,00 244400 244400 0 0,00 
14 
Pavlodar 195 331 195 331 93 0,05 264992 264992 44 0,02 243772 243772 107 0,04 
15 
Semipalatinsk region  706 733 706 733 1514 0,21 596000 596000 1098 0,18 613500 613500 1890 0,31 
16 North kazakhstan Oblast 92 500 92 500 6 0,01 165500 165500 6 0,00 117500 117500 0 0,00 
17 South Kazakhstan Oblast 2 203 759 2 203 759 1240 0,06 3583107 3583107 1684 0,05 2312261 2312261 3536 0,15 
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1 Akmola 396330 396330 214 0,05 464 630 464 630 466 0,10 612510 190729 298 0,16 
2 Aktiobinsk 1428680 1428680 3242 0,23 1 497 450 1 497 450 3081 0,21 2167700 520733 715 0,14 
3 Taldykorgan region  2054640 2054640 2072 0,10 1928640 1928640 4936 0,26 3029830 469673 1006 0,21 
4 
Almaty region 2260880 2260880 4158 0,18 2 236 872 2 236 872 2584 0,12 2710600 493558 44 0,01 
5 Atirau 788370 788370 440 0,06 832 500 832 500 435 0,05 1112300 323260 181 0,06 
6 East Kazakhstan Oblast 1402895 1402895 7775 0,55 1 287 900 1 287 900 4646 0,36 1917300 487396 1898 0,39 
7 Zhambul 3021150 3021150 9988 0,33 3 556 000 3 556 000 9743 0,27 4327500 1403384 6645 0,47 
8 West Kazakhstan Oblast 1100990 1100990 1403 0,13 1 077 000 1 077 000 1652 0,15 1411453 205790 298 0,14 
9 Karaganda 963700 963700 1343 0,14 949 550 949 550 640 0,07 1458500 280480 452 0,16 
10 Zhezkazgan region  385450 385450 0 0,00 384 450 384 450 0 0,00 470000 96253 0 0,00 
11 Kostanai 404250 404250 947 0,23 418 150 418 150 1786 0,43 559670 128274 244 0,19 
12 Kyzylorda 1015960 1015960 1340 0,13 1 100 000 1 100 000 721 0,07 1480700 448785 290 0,06 
13 Mangistau 728090 728090 0 0,00 793 000 793 000 0 0,00 1050000 352739 0 0,00 
14 Pavlodar 634920 634920 369 0,06 680 100 680 100 663 0,10 986824 238443 361 0,15 
15 Semipalatinsk region  1837045 1837045 6796 0,37 1 710 000 1 710 000 3710 0,22 2406800 841446 1678 0,20 




4736497 4736497 3823 0,08 5 348 029 5 348 029 2370 0,04 6742119 1508009 1204 0,08 
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2012  2013  2014  2015  
8months of 2016  
Tested Positive inc. 
. 
 
Tested Positive inc. 
 
Tested Positive inc. 
 
Tested Positive inc. 
 
Tested Positive inc. 
 
Akmola 459450 1188 0,3 324 725 338 0,1 294277 291 0,1 286610 219 0,076 350447 1500 0,42 
Aktiobinsk 1779791 2826 0,16 1 272 205 3 514 0,3 816987 3953 0,5 1065330 3570 0,33 760 212 1 126 0,1 
 Atirau  749251 332 0,04 630 342 1 206 0,2 538350 1 853 0,3 569266 1813 0,31 
418339 2222 0,53 
Almaty region 4168639 5056 0,12 2 524 249 6 339 0,25 2269125 9407 0,45 2949833 7239 0,25 2961311 4734 0,16 
East Kazakhstan 
Oblast 
4143644 9918 0,26 1 846 384 7 680 0,45 1635215 9258 0,55 2292458 8042 0,37 
1403835 3354 0,25 
Zhambul 4356382 11540 0,3 1 997 377 9 145 0,5 1953593 11647 0,5 1989035 4996 0,25 1397654 2842 0,2 
West Kazakhstan 
Oblast 
1090654 3085 0,28 805 565 2 042 0,3 724335 2077 0,2 1016815 2838 0,27 709015 915 
0,13 
Karaganda 1516300 614 0,02 771 872 343 0,05 666144 932 0,1 1277669 1024 0,05 1027640 210 0,02 
Kyzylorda 990 782 636 0,06 804 370 502 0,1 671469 916 0,1 497741 195 0,039 514556 100 0,01 
Kostanai 350013 388 0,11 404 311 558 0,1 300000 694 0,2 359902 261 0,073 41677 92 0,02 
Mangistau 655769 0 0 612 417 0 0 427316 0 0 403341 0 0 275257 2 0 
Pavlodar 645840 472 0,07 552 310 205 0 509992 1371 0,2 593203 889 0,15 656490 370 0,06  
North kazakhstan 
Oblast 
364872 35 0,01 342 783 79 0 283339 34 0 327674 24 0,07 
355024 11 0,003 
South Kazakhstan 
Oblast 
6415035 2422 0,04 4 246 087 2 336 0,1 4190421 2982 0 3242790 1449 0,045 
1331414 953 0,07 
Astana city 1530 28 1,83 150 741 1 813 1,2 146768 2393 1,6 190111 2051 1,07 618 14 2,2 
Total 27687952 38540 0,13 7285738 36 100 0,5 15143992 47808 0,3 17061778 34610 0,2 12203489 18445 0,3 
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1. Aqmola 9 1,2 10 1,3 14 1,9 
2. Aqtobe 38 5,5 36 5,2 29 4,1 
3. Almaty 370 22,9 316 19,4 528 31,9 
4. Atyrau 4 0,8 2 0,4 5 1,0 
5. East 
Kazakhstan 
224 15,7 278 19,4 247 17,4 
6. Zhambyl 630 62,7 527 52,0 527 51,4 
7. West 
Kazakhstan 
43 7,0 18 3,0 26 4,2 
8. Qaraghandy 53 4,0 24 1,8 42 3,1 
9. Qostanay 8 0,9 8 0,9 16 1,8 
10. Qyzylorda 347 55,8 232 36,9 206 32,3 
11. Mangghystau 0 0,0 1 0,3 1 0,2 
12. Pavlodar 18 2,4 8 1,1 15 2,0 
13. North 
Kazakhstan 
5 0,8 1 0,2 0 0,0 
14. South 
Kazakhstan 
913 40,4 811 35,2 918 38,9 
15 Almaty city 5 0,4 2 0,2 2 0,2 
16. Astana city 3 0,5 6 1,0 1 0,2 
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1. Aqmola 7 0,9 35 4,75 31 4,2 22 3,01 40 5,45 
2. Aqtobe 37 5,2 32 4,43 29 3,7 33 4,18 28 3,5 
3. Almaty 467 26,3 515 30,16 416 21,8 377 19,65 316 16,1 
4. Atyrau 6 1,4 14 2,7 11 2,07 6 1,1 23 4,1 
5. East Kazakhstan 239 16,8 221 15,5 197 14,1 134 9,6 125 8,97 
6. Zhambyl 441 39,8 395 37,63 388 36,6 310 29,2 288 26,8 
7. West Kazakhstan 46 7,4 61 9,73 55 9,03 55 8,9 52 8,4 
8. Qaraghandy 38 2,8 29 2,14 28 2,1 26 1,9 12 0,8 
9. Qostanay 7 0,78 7 0,79 3 0,34 4 0,45 6 0,68 
10 Qyzylorda 135 21,1 122 17,52 137 20,3 83 11,58 84 11,5 
11 Mangghystau 1 0,2 1 0,22 0 0 0 0,0 0 0 
12 Pavlodar 15 2,0 26 3,46 25 3,3 23 3,08 23 3,07 
13 North Kazakhstan 1 0,15 3 0,47 7 0,82 6 1,03 5 0,86 
14 South Kazakhstan 683 27,3 679 27,65 463 17,6 425 16,12 436 16,1 
15 Almaty city 6 0,5 3 0,21 2 0,13 0 0,0 1 0,07 
16 Astana city 11 1,6 10 1,42 8 1,1 5 0,67 4 0,5 
Total  2110 13,3 2153 13,3 1800 10,9 1509 9,02 1443 8,49 
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1. Aqmola 25 3,4 28 3,7 5 0,6 
2. Aqtobe 24 2,9 44 5,3 16 1,9 
3. Almaty 278 14,6 237 12,2 77 3,9 
4. Atyrau 15 2,61 25 4,25 23 3,9 
5. East Kazakhstan 140 10,0 103 7,3 49 3,5 
6. Zhambyl 280 25,7 252 22,8 70 6,3 
7. West Kazakhstan 53 8,4 62 9,7 13 2,0 
8. Qaraghandy 18 1,3 16 1,1 6 0,4 
9. Qostanay 16 1,8 44 4,9 24 2,7 
10. Qyzylorda 82 11,0 91 12,0 32 4,2 
11. Mangghystau 2 0,33 2 0,3 1 0,1 
12. Pavlodar 16 2,12 26 3,4 9 1,1 
13. North Kazakhstan 4 0,7 7 1,2 0 0 
14. South Kazakhstan 482 17,5 382 13,6 119 4,2 
15 Almaty city 4 0,25 2 0,1 3 0,1 
16. Astana city 4 0,48 13 1,5 1 0,12 
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1334 7.7 1131 84.8 184 13.8 75 5.6 1218 
 1 0.1In total
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